Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
2013
DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages
2006
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA
2013
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
2014
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
2010
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
2016
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
2016
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
2017
Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing
2004
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma
2014
Finishing the euchromatic sequence of the human genome
2004 StandoutNature
Genome-scale DNA methylation maps of pluripotent and differentiated cells
2008 StandoutNature
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
2014
mRNA-based dendritic cell vaccines
2014
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
mRNA Cancer Vaccines—Messages that Prevail
2017
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients
2003
Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
2011
Lessons from the post-genomic era: Globin diversity beyond oxygen binding and transport
2020
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
2021
Alternative isoform regulation in human tissue transcriptomes
2008 StandoutNature
Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition
2013
mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes
2007
The European Regulatory Environment of RNA-Based Vaccines
2016
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
2007 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
The landscape of mRNA nanomedicine
2022
Immunotherapy at Large: The road to personalized cancer vaccines
2013
Developmental programming of CpG island methylation profiles in the human genome
2009
Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
2016
RNA: The new revolution in nucleic acid vaccines
2013
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
2014 Nature
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
2015
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA
2007
Tumor vaccination using messenger RNA: prospects of a future therapy
2011
mRNA
2013
Identification of cancer/testis genes by database mining and mRNA expression analysis
2002
Identification and Characterization of a Novel Cancer/Testis Antigen Gene CAGE
2002
The cancer antigenome
2012
FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
2016
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
2012
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Personalized cancer vaccines: Targeting the cancer mutanome
2016
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
2014
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity
2019
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
2011
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
2002
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
2017
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
2016
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
2014
A novel, disruptive vaccination technology
2013
mRNA vaccines manufacturing: Challenges and bottlenecks
2021
The ReNAissanCe of mRNA-based cancer therapy
2014
Characterization of sperm protein 17 in human somatic and neoplastic tissue
2002
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
2000
Identification of specific autoantigens in Sjögren's syndrome by SEREX
2005
Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
2012
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Human tumor antigens for cancer vaccine development
1999
Antigens for cancer immunotherapy
2008
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
2011
mRNA transcript therapy
2014 StandoutNobel
Vaccination with Messenger RNA (mRNA)
2007
Cancer immunotherapy comes of age
2011 StandoutNature
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
2014
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
2010
Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
2014
Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
2015
Developing mRNA-vaccine technologies
2012
Prophylactic mRNA vaccination against allergy
2010
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Expression of cancer/testis (CT) antigens in lung cancer
2003
Immune targets and neoantigens for cancer immunotherapy and precision medicine
2016
The dawn of mRNA vaccines: The COVID-19 case
2021
Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
2010 Standout
Lipid-based mRNA vaccine delivery systems
2014
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 Nature
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
2016
Human DNA methylomes at base resolution show widespread epigenomic differences
2009 StandoutNature
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
2019
Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
2003
Targeting the tumor mutanome for personalized vaccination therapy
2012
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
RNA-based vaccines
2012
mRNA Cancer Vaccines
2016
Antitumor Vaccination with Synthetic mRNA: Strategies for In Vitro and In Vivo Preclinical Studies
2012
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
2000
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.
2000
2015
Improving Protein Expression, Stability, and Function with ProteinMPNN
2024 StandoutNobel
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
2014
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety
2021
Emerging mRNA technologies: delivery strategies and biomedical applications
2022
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
1997
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Identification on a human sarcoma of two new genes with tumor-specific expression.
2000
Human Tumor Antigens and Cancer Immunotherapy
2015
Analysis of the B‐cell repertoire against antigens expressed by human neoplasms
2002
mRNA Vaccine Delivery Using Lipid Nanoparticles
2016
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
2013
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals
2008
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
2002
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
2021
Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen
2000
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies
2002
Tools for translation: non-viral materials for therapeutic mRNA delivery
2017
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
RNA-Based Vaccines in Cancer Immunotherapy
2015
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer
2014
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
1998
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
2016
CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
2000
Cancer Genome Landscapes
2013 StandoutScience
Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
2012
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
2015
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
2004
The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma
2018
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
2004
The cancer/testis genes: review, standardization, and commentary.
2004
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice
2011 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
1998
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Therapeutic cancer vaccines
2015
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
2001
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
2015
Personalized vaccines for cancer immunotherapy
2018 Science
Serological analysis of human tumor antigens: molecular definition and implications
1997
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Serological detection of cutaneous T-cell lymphoma-associated antigens
2001
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Michael Koslowski being referenced
Frequent Nonrandom Activation of Germ-Line Genes in Human Cancer
2004
A Placenta-Specific Gene Ectopically Activated in Many Human Cancers Is Essentially Involved in Malignant Cell Processes
2007
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
2010
FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
2011
Exploiting the Mutanome for Tumor Vaccination
2012
MS4A12 Is a Colon-Selective Store-Operated Calcium Channel Promoting Malignant Cell Processes
2008
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
2013
Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α
2010
Identification of new claudin family members by a novel PSI‐BLAST based approach with enhanced specificity
2006
A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer
2011
Confidence-based Somatic Mutation Evaluation and Prioritization
2012
A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing
2002
Old proteins – new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells
2010
Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
2011
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
2008
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.
2002
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.
1996
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
2006
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens
1998
Expression of cancer testis genes in human brain tumors.
2000